Alberta Investment Management Corp Maxcyte, Inc. Transaction History

Alberta Investment Management Corp

  • $10.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$3.94 - $5.38 $104,764 - $143,054
-26,590 Reduced 19.53%
109,545 $458,000
Q4 2023

Feb 12, 2024
SELL
$2.6 - $5.24 $165,588 - $333,725
-63,688 Reduced 31.87%
136,135 $639,000
Q3 2023

Nov 14, 2023
BUY
$3.02 - $5.1 $69,493 - $117,356
23,011 Added 13.01%
199,823 $623,000
Q2 2023

Aug 14, 2023
BUY
$3.69 - $5.35 $652,436 - $945,944
176,812 New
176,812 $811,000

Others Institutions Holding MXCT

# of Institutions
124
Shares Held
65.6M
Call Options Held
1K
Put Options Held
2K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $426M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email